Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Robert Guertin

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Technology Assessment in Health Care|February 25, 2025
Perception of non-layperson advisory committee members on the application of a discrete choice experiment instrument to patients and advisory committee members: a qualitative studyHung Manh Nguyen, Jason Robert Guertin, Daniel Reinharz
International Journal of Technology Assessment in Health Care|June 25, 2025
Environmental considerations in health technology assessments performed by Canadian agenciesElodie Bénard, Komi Edem Gatovo, Jason Robert Guertin
Journal of Medical Economics|October 26, 2011
Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrheaAlvine Adrienne Kamdeu Fansi, Jason Robert Guertin, Jacques LeLorier
Clinicoeconomics and Outcomes Research : CEOR|September 19, 2024
Adjusting Historical Costs for Inflation with the Use of Standardized Automated ToolsJason Robert Guertin, Naomi Hope Chouinard, Amélie Forget, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
The Health Economics of Metastatic Hormone-Sensitive and Non-Metastatic Castration-Resistant Prostate Cancer-A Systematic Literature Review with Application to the Canadian ContextIvan Yanev, Jessy Gatete, Armen G Aprikian, et al.
Journal of Gynecology Obstetrics and Human Reproduction|January 31, 2025
Modelling the cost effectiveness and budget impact of uterine botulinum toxin injections versus conventional treatment in severe dysmenorrhoea: A French perspectiveJean Martial Kouame, Jason Robert Guertin, Éric Bautrant, et al.
Palliative & Supportive Care|March 10, 2026
End of life distress as an economic issue: The case for psychedelic-assisted therapy - ERRATUMMichel Dorval, Virginie Audet-Croteau, Sue-Ling Chang, et al.
Palliative & Supportive Care|January 28, 2026
End of life distress as an economic issue: The case for psychedelic-assisted therapyMichel Dorval, Virginie Audet-Croteau, Sue-Ling Chang, et al.
Journal of Clinical Epidemiology|February 15, 2025
Author's reply: "The importance of properly specifying your target trial emulation: commentary on Mésidor et al."Miceline Mésidor, Caroline Sirois, Jason Robert Guertin, et al.
Canadian Liver Journal|December 28, 2023
Canadian trends in spending on liver hospitalizations and transplants: 2004-2020Keqing Zhao, Ahmad Shakeri, Pooyeh Graili, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Technology Assessment in Health Care|February 25, 2025
Perception of non-layperson advisory committee members on the application of a discrete choice experiment instrument to patients and advisory committee members: a qualitative studyHung Manh Nguyen, Jason Robert Guertin, Daniel Reinharz
International Journal of Technology Assessment in Health Care|June 25, 2025
Environmental considerations in health technology assessments performed by Canadian agenciesElodie Bénard, Komi Edem Gatovo, Jason Robert Guertin
Journal of Medical Economics|October 26, 2011
Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrheaAlvine Adrienne Kamdeu Fansi, Jason Robert Guertin, Jacques LeLorier
Clinicoeconomics and Outcomes Research : CEOR|September 19, 2024
Adjusting Historical Costs for Inflation with the Use of Standardized Automated ToolsJason Robert Guertin, Naomi Hope Chouinard, Amélie Forget, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
The Health Economics of Metastatic Hormone-Sensitive and Non-Metastatic Castration-Resistant Prostate Cancer-A Systematic Literature Review with Application to the Canadian ContextIvan Yanev, Jessy Gatete, Armen G Aprikian, et al.
Journal of Gynecology Obstetrics and Human Reproduction|January 31, 2025
Modelling the cost effectiveness and budget impact of uterine botulinum toxin injections versus conventional treatment in severe dysmenorrhoea: A French perspectiveJean Martial Kouame, Jason Robert Guertin, Éric Bautrant, et al.
Palliative & Supportive Care|March 10, 2026
End of life distress as an economic issue: The case for psychedelic-assisted therapy - ERRATUMMichel Dorval, Virginie Audet-Croteau, Sue-Ling Chang, et al.
Palliative & Supportive Care|January 28, 2026
End of life distress as an economic issue: The case for psychedelic-assisted therapyMichel Dorval, Virginie Audet-Croteau, Sue-Ling Chang, et al.
Journal of Clinical Epidemiology|February 15, 2025
Author's reply: "The importance of properly specifying your target trial emulation: commentary on Mésidor et al."Miceline Mésidor, Caroline Sirois, Jason Robert Guertin, et al.
Canadian Liver Journal|December 28, 2023
Canadian trends in spending on liver hospitalizations and transplants: 2004-2020Keqing Zhao, Ahmad Shakeri, Pooyeh Graili, et al.
Pageof 6